1. The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer
    Desheng Lv et al, 2016, Tumor Biol. CrossRef
  2. From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma
    Hong Yang et al, 2017 CrossRef
  3. The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma
    Fang-Yi Fan et al, 2017 CrossRef
  4. Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1
    Ruirui Cheng et al, 2017 CrossRef
  5. β-catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl
    JIN ZHANG et al, 2016 CrossRef
  6. Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response
    Abril Marcela Herrera-Solorio et al, 2017, Clin Epigenet CrossRef
  7. Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway
    Yíng Wang et al, 2017, J Cell Physiol CrossRef
  8. Transcriptome analysis of EGFR tyrosine kinase inhibitors resistance associated long noncoding RNA in non-small cell lung cancer
    Pei Ma et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  9. Long non-coding RNA MEG3 inhibits the proliferation and metastasis of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway
    Zongxiang Liu et al, 2017 CrossRef
  10. Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer
    He Li et al, 2017 CrossRef
  11. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer
    Gang Yang et al, 2018, J Cell Mol Med CrossRef
  12. Long noncoding RNAs in cancer cells
    Duc-Hiep Bach et al, 2018, Cancer Letters CrossRef
  13. Double Determination of Long Noncoding RNAs from Lung Cancer via Multi-amplified Electrochemical Genosensor at Sub-femtomole Level
    Xiaoyan Li et al, 2018, Biosensors and Bioelectronics CrossRef
  14. Role of long non-coding RNA in drug resistance in non-small cell lung cancer.
    Leirong Wang et al, 2018, Thorac Cancer CrossRef
  15. Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31
    Shujuan Yang et al, 2018, J. Cell. Biochem. CrossRef
  16. Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy
    Binbin Ma et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  17. Systematic identification of non-coding pharmacogenomic landscape in cancer
    Yue Wang et al, 2018, Nat Commun CrossRef
  18. Association Between Long Noncoding RNA MEG3 Polymorphisms and Lung Cancer Susceptibility in Chinese Northeast Population
    Zitai Yang et al, 2018, DNA and Cell Biology CrossRef
  19. The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta-analysis
    Maryam Moradi Binabaj et al, 2018, J Cell Biochem CrossRef
  20. MEG3 is increased in idiopathic pulmonary fibrosis and regulates epithelial cell differentiation
    Jason J. Gokey et al, 2018 CrossRef
  21. Identification of abnormally expressed lncRNAs induced by PM2.5 in human bronchial epithelial cells
    Xing Li et al, 2018, Biosci. Rep. CrossRef
  22. Interaction of long noncoding RNA MEG3 with miRNAs: A reciprocal regulation
    Mohammad-Taher Moradi et al, 2018, J Cell Biochem CrossRef
  23. Long noncoding RNAs as biotargets in cisplatin-based drug resistance
    Nadiah Abu et al, 2018, Future Oncology CrossRef
  24. Long noncoding RNA OIP5‐AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR‐340‐5p
    Lei Song et al, 2018, J Cell Biochem CrossRef
  25. Silencing long non‐coding RNA MEG3 accelerates tibia fraction healing by regulating the Wnt/β‐catenin signalling pathway
    Yu‐Bao Liu et al, 2019, J Cell Mol Med CrossRef
  26. Long non-coding RNAs as regulators of Wnt/β catenin pathway
    Mahya Astaneh et al, 2019, Gene Reports CrossRef
  27. Silence of MEG3 intensifies lipopolysaccharide-stimulated damage of human lung cells through modulating miR-4262
    Xiaoliang Li et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  28. Cardio-protective effects of salvianolic acid B on oxygen and glucose deprivation (OGD)-treated H9c2 cells
    Bin Yang et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  29. Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA.
    Soudeh Ghafouri-Fard et al, 2019, Biomed Pharmacother CrossRef
  30. Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types
    Yanjiao Zhu et al, 2019, Genomics CrossRef
  31. Negative regulators of Wnt signaling in non-small cell lung cancer: Theoretical basis and therapeutic potency
    Zikuan Song et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  32. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163
    Lin Su et al, 2016, Tumor Biol. CrossRef
  33. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway
    Yali Gao et al, 2016, Tumor Biol. CrossRef
  34. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer
    Battseren Bayarmaa et al, 2019, BMC Cancer CrossRef
  35. Long Non-Coding RNA in the Pathogenesis of Cancers.
    Yujing Chi et al, 2019, Cells CrossRef
  36. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis
    Yuan Wang et al, 2016, Cancer Letters CrossRef
  37. Long noncoding and circular RNAs in lung cancer: advances and perspectives
    Weijia Xie et al, 2016, Epigenomics CrossRef
  38. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
    Wei Zhang et al, 2017, Biomed Pharmacother CrossRef
  39. DLK1-DIO3imprinted locus deregulation in development, respiratory disease, and cancer
    Jhon R. Enterina et al, 2017, Expert Review of Respiratory Medicine CrossRef
  40. Long-Noncoding RNAs (lncRNAs) in Drug Metabolism and Disposition, Implications in Cancer Chemo-resistance
    Yue Wang et al, 2019, Acta Pharmaceutica Sinica B CrossRef
  41. Chemerin-induced angiogenesis and adipogenesis in 3 T3-L1 preadipocytes is mediated by lncRNA Meg3 through regulating Dickkopf-3 by sponging miR-217
    Xianwei Huang et al, 2019, Toxicology and Applied Pharmacology CrossRef
  42. Long Non-Coding RNA in Drug Resistance of Non-Small Cell Lung Cancer: A Mini Review
    Ruizheng Sun et al, 2019, Front. Pharmacol. CrossRef
  43. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
    Wenxiao Jiang et al, 2020, Drug Resistance Updates CrossRef
  44. null
    David Hanly et al, 2019 CrossRef
  45. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin
    Yefeng Ji et al, 2020, Cancer Med CrossRef
  46. Non-Coding RNAs in Lung Tumor Initiation and Progression
    Ruben Mercado Santos et al, 2020, IJMS CrossRef
  47. Up-regulation of LINC00161 correlates with tumor migration and invasion and poor prognosis of patients with hepatocellular carcinoma
    Li-Chao Xu et al, 2017, Oncotarget CrossRef
  48. Potential applications of MEG3 in cancer diagnosis and prognosis
    Yuqing He et al, 2017, Oncotarget CrossRef
  49. Long non-coding RNA deep sequencing reveals the role of macrophage in liver disorders
    Zhang Lin et al, 2017, Oncotarget CrossRef
  50. Subpathway-LNCE: Identify dysfunctional subpathways competitively regulated by lncRNAs through integrating lncRNA-mRNA expression profile and pathway topologies
    Xinrui Shi et al, 2016, Oncotarget CrossRef
  51. Exosomal Long Non-Coding RNAs in Lung Diseases
    Christophe Poulet et al, 2020, IJMS CrossRef
  52. Roles of Wnt/β-Catenin Signaling Pathway Regulatory Long Non-Coding RNAs in the Pathogenesis of Non-Small Cell Lung Cancer.
    Shan Lin et al, 2020, Cancer Manag Res CrossRef
  53. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells
    Hongchang Li et al, 2020, J Clin Lab Anal CrossRef
  54. Role of noncoding RNAs in cholangiocarcinoma (Review)
    Yinghao Lv et al, 2020, Int J Oncol CrossRef
  55. Interaction of long-chain non-coding RNAs and important signaling pathways on human cancers (Review)
    Wei Sun et al, 2018, Int J Oncol CrossRef
  56. Long non‑coding RNA ENST00000500843 is downregulated and promotes chemoresistance to paclitaxel in lung adenocarcinoma
    Xin Tian et al, 2019, Oncol Lett CrossRef
  57. Functional impact of the long non‑coding RNA MEG3 deletion by CRISPR/Cas9 in the human triple negative metastatic Hs578T cancer cell line
    Carlos Deocesano‑Pereira et al, 2019, Oncol Lett CrossRef
  58. The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line
    Chengji Jin et al, 2019, Oncol Lett CrossRef
  59. Knockdown of DNA‐binding protein A enhances the chemotherapy sensitivity of colorectal cancer via suppressing the Wnt/β‐catenin/Chk1 pathway
    Cong Tong et al, 2020, Cell Biol Int CrossRef
  60. The role of long non‐coding RNAs in drug resistance of cancer
    He‐da Zhang et al, 2020, Clinical Genetics CrossRef
  61. Chemotherapy and chemo-resistance in nasopharyngeal carcinoma
    Shuzhen Guan et al, 2020, European Journal of Medicinal Chemistry CrossRef
  62. Tissue-based long non-coding RNAs “PVT1, TUG1 and MEG3” signature predicts Cisplatin resistance in ovarian Cancer
    Nashwa El-Khazragy et al, 2020, Genomics CrossRef
  63. Mechanisms of drug resistance mediated by long non-coding RNAs in non-small-cell lung cancer
    Manuela La Montagna et al, 2020, Cancer Gene Ther CrossRef
  64. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
    Wangkai Xie et al, 2020, Seminars in Cancer Biology CrossRef
  65. LncRNAs and miRNAs participate in determination of response of cancer cells to cisplatin
    Mohammad Taheri et al, 2021, Experimental and Molecular Pathology CrossRef
  66. Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling
    L. Gao et al, 2021, Clin Transl Oncol CrossRef
  67. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer
    Yu Chen et al, 2021, Clinical and Translational Medicine CrossRef
  68. Role of Long Non-Coding RNA Polymorphisms in Cancer Chemotherapeutic Response
    Zheng Zhang et al, 2021, JPM CrossRef
  69. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway
    Chang-Jun Tong et al, 2021, Aging CrossRef
  70. Anticancer effects of melatonin via regulating lncRNA JPX‐Wnt/β‐catenin signalling pathway in human osteosarcoma cells
    Yuan Li et al, 2021, J Cell Mol Med CrossRef
  71. Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy
    Rui Guo et al, 2022, Front. Oncol. CrossRef
  72. Sitagliptin Potentiates the Anti-Neoplastic Activity of Doxorubicin in Experimentally-Induced Mammary Adenocarcinoma in Mice: Implication of Oxidative Stress, Inflammation, Angiogenesis, and Apoptosis
    Mohamed M. Salama et al, 2022, Sci. Pharm. CrossRef
  73. A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers
    Jie Xu et al, 2022, Front. Cell Dev. Biol. CrossRef
  74. Macrophage migration inhibitory factor protects bone marrow mesenchymal stem cells from hypoxia/ischemia-induced apoptosis by regulating lncRNA MEG3
    Zhibiao Bai et al, 2022, J. Zhejiang Univ. Sci. B CrossRef
  75. The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer
    Yiyang Sun et al, 2023, Front. Oncol. CrossRef
  76. Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer
    Priya Mondal et al, 2023, Front. Pharmacol. CrossRef
  77. Long noncoding ribonucleic acids maternally expressed gene 3 inhibits lung cancer tumor progression through downregulation of MYC
    L Yan-hua et al, 2015, Indian J Cancer CrossRef
  78. The relationship between long non-coding RNAs and Wnt/β-catenin signaling pathway in the pathogenesis of Alzheimer’s disease
    Ali Ghasemi et al, 2023, Experimental Neurology CrossRef
  79. HOTAIR in colorectal cancer: structure, function, and therapeutic potential
    Muhammad Tufail, 2023, Med Oncol CrossRef
  80. Long Non-Coding RNAs in Lung Cancer: Unraveling the Molecular Modulators of MAPK Signaling
    Md Sadique Hussain et al, 2023, Pathology - Research and Practice CrossRef
  81. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles
    Xinxin Meng et al, 2023, Environmental Research CrossRef
  82. Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistance
    Wenjuan Liu et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  83. Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
    Maliheh Entezari et al, 2024, CCDT CrossRef
  84. Long non-coding RNA and Evolving drug resistance in lung cancer
    Meibin Wang et al, 2023, Heliyon CrossRef
  85. Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma
    Rawan Amr Elmasri et al, 2024, Non-coding RNA Research CrossRef
  86. Anti-breast cancer activity of the essential oil from grapefruit mint (Mentha suaveolens × piperita)
    Zohreh Jahanafrooz et al, 2024, Fitoterapia CrossRef